LIGUORO, DOMENICO
 Distribuzione geografica
Continente #
NA - Nord America 385
EU - Europa 378
AS - Asia 111
AF - Africa 3
Totale 877
Nazione #
US - Stati Uniti d'America 382
IT - Italia 178
IE - Irlanda 127
SG - Singapore 47
AT - Austria 32
IN - India 18
CN - Cina 14
TW - Taiwan 12
ID - Indonesia 10
DE - Germania 6
BG - Bulgaria 5
IR - Iran 5
BE - Belgio 4
CA - Canada 3
GB - Regno Unito 3
NL - Olanda 3
RO - Romania 3
SE - Svezia 3
UA - Ucraina 3
UG - Uganda 3
FR - Francia 2
JP - Giappone 2
PT - Portogallo 2
RS - Serbia 2
CH - Svizzera 1
ES - Italia 1
HK - Hong Kong 1
IL - Israele 1
KR - Corea 1
MK - Macedonia 1
PL - Polonia 1
RU - Federazione Russa 1
Totale 877
Città #
Dublin 127
Rome 69
Fairfield 52
Ashburn 47
Singapore 38
Woodbridge 31
Seattle 29
Vienna 29
Houston 26
Chandler 25
Wilmington 21
Cambridge 15
Santa Clara 13
Jakarta 10
San Paolo di Civitate 9
New York 8
Millbury 7
Naples 7
Princeton 7
Cagliari 6
Daan 6
Lawrence 6
Rogliano 6
Padova 5
Sofia 5
Beijing 4
Hsinchu 4
Ternat 4
Andover 3
Ann Arbor 3
Aprilia 3
Campobasso 3
Cavallino 3
Dearborn 3
Gattatico 3
Mbarara 3
Ortona 3
San Diego 3
Turin 3
Belgrade 2
Boardman 2
Carife 2
Castrocielo 2
Columbus 2
Des Moines 2
Formia 2
Genazzano 2
Milan 2
Minturno 2
Mumbai 2
Nanjing 2
Palo Alto 2
Porto 2
Pune 2
Redwood City 2
Stevenage 2
Stockholm 2
Taipei 2
Toronto 2
Amsterdam 1
Avellino 1
Boca Raton 1
Bologna 1
Boston 1
Bremen 1
Chengdu 1
Concord 1
Dongguan 1
Falconara Marittima 1
Florence 1
Foshan 1
Frosinone 1
Guangzhou 1
Hamburg 1
Jacksonville 1
Jinan 1
Kavadarci 1
Latina 1
Los Angeles 1
Mannheim 1
Moscow 1
Napoli 1
Norwalk 1
Pasadena 1
Phoenix 1
Plano 1
Poway 1
Shanghai 1
Tarnaveni 1
Tel Aviv 1
Tokyo 1
Tuen Mun 1
Valencia 1
Yingkou 1
Totale 724
Nome #
ErbB3 Phosphorylation as Central Event in Adaptive Resistance to Targeted Therapy in Metastatic Melanoma. Early Detection in CTCs during Therapy and Insights into Regulation by Autocrine Neuregulin 144
Single cell analysis to dissect molecular heterogeneity and disease evolution in metastatic melanoma 111
Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance 94
miR-579-3p restrains tumor heterogeneity to overcome resistance to target therapies in metastatic melanoma 86
Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma 81
In vitro biophysical and biological characterization of lipid nanoparticles Co-encapsulating oncosuppressors miR-199b-5p and miR-204-5p as potentiators of target therapy in metastatic melanoma 72
miR-125a-5p impairs the metastatic potential in breast cancer via IP6K1 targeting 71
null 63
The promise of liquid biopsy to predict response to immunotherapy in metastatic melanoma 61
Drug tolerance to target therapy in melanoma revealed at single cell level: What next? 41
ERK signaling pathway is constitutively active in NT2D1 non-seminoma cells and its inhibition impairs basal and HGF-activated cell proliferation 29
Identification of a miRNA-based non-invasive predictive biomarker of response to target therapy in BRAF-mutant melanoma 28
Radioresistance Mechanisms in Prostate Cancer Cell Lines Surviving Ultra-Hypo-Fractionated EBRT: Implications and Possible Clinical Applications 26
The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitors 16
Upregulated expression of miR-4443 and miR-4488 in drug resistant melanomas promotes migratory and invasive phenotypes through downregulation of intermediate filament nestin 10
Totale 933
Categoria #
all - tutte 3.201
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.201


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202077 0 0 0 0 0 14 18 11 15 14 2 3
2020/202191 3 6 0 40 10 2 3 6 1 14 5 1
2021/2022152 15 5 5 11 11 1 4 15 14 8 47 16
2022/2023229 13 24 6 16 22 17 7 15 106 0 3 0
2023/2024216 16 14 12 24 11 33 18 32 6 12 17 21
2024/2025120 10 16 14 27 28 25 0 0 0 0 0 0
Totale 933